FOMX
Bank of New York Mellon’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-277,096
| Closed | -$659K | – | 4264 |
|
|
2019
Q2 | $659K | Sell |
277,096
-123,438
| -31% | -$294K | ﹤0.01% | 3461 |
|
|
2019
Q1 | $1.5M | Sell |
400,534
-62,977
| -14% | -$236K | ﹤0.01% | 2933 |
|
|
2018
Q4 | $1.66M | Sell |
463,511
-172,616
| -27% | -$620K | ﹤0.01% | 2824 |
|
|
2018
Q3 | $3.65M | Buy |
636,127
+134,676
| +27% | +$772K | ﹤0.01% | 2542 |
|
|
2018
Q2 | $2.51M | Sell |
501,451
-380
| -0.1% | -$1.9K | ﹤0.01% | 2731 |
|
|
2018
Q1 | $2.58M | Sell |
501,831
-34,083
| -6% | -$175K | ﹤0.01% | 2674 |
|
|
2017
Q4 | $3.22M | Sell |
535,914
-35,725
| -6% | -$215K | ﹤0.01% | 2568 |
|
|
2017
Q3 | $3.17M | Buy |
571,639
+26,786
| +5% | +$149K | ﹤0.01% | 2561 |
|
|
2017
Q2 | $2.53M | Buy |
544,853
+151,849
| +39% | +$705K | ﹤0.01% | 2712 |
|
|
2017
Q1 | $1.95M | Sell |
393,004
-127,482
| -24% | -$631K | ﹤0.01% | 2868 |
|
|
2016
Q4 | $5.78M | Sell |
520,486
-3,988
| -0.8% | -$44.3K | ﹤0.01% | 2244 |
|
|
2016
Q3 | $4.86M | Sell |
524,474
-26,876
| -5% | -$249K | ﹤0.01% | 2250 |
|
|
2016
Q2 | $3.5M | Sell |
551,350
-67,230
| -11% | -$427K | ﹤0.01% | 2402 |
|
|
2016
Q1 | $4.03M | Sell |
618,580
-32,151
| -5% | -$210K | ﹤0.01% | 2290 |
|
|
2015
Q4 | $5.28M | Sell |
650,731
-119,828
| -16% | -$972K | ﹤0.01% | 2178 |
|
|
2015
Q3 | $5.65M | Buy |
770,559
+114,680
| +17% | +$841K | ﹤0.01% | 2170 |
|
|
2015
Q2 | $6.72M | Buy |
+655,879
| New | +$6.72M | ﹤0.01% | 2179 |
|